Effect of Photobiomodulation in Patients With Temporomandibular Dysfunction Refractory to Botulinum Toxin Treatment.

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Temporomandibular Joint Disorder
Interventions
DEVICE

Low- level laser- photobiomodulation therapy

Three patients (30%) received treatment on the left side and seven (70%) on the right side. The treatment was carried out using the EPIC X laser (BIOLASE®), which uses a solid-state diode as a semiconductor source of invisible infrared radiation. The therapy was applied to the masticatory muscles (temporal, masseter, internal pterygoid), to trigger points discovered on palpation and to the intra-articular area of the TMJ (posterior portion through the external ear, superior portion and anterior portion). All patients included in the study underwent four sessions of PBMT-LLL for four consecutive weeks. T

Trial Locations (1)

37007

Department of Maxillofacial Surgery at the University Hospital Complex of Salamanca, Salamanca

All Listed Sponsors
collaborator

University of Salamanca

OTHER

lead

University of Coimbra

OTHER